Omeprazole Sodium (CAS No 95510-70-6) is a proton pump inhibitor used extensively in biomedical research due to its ability to reduce gastric acid secretion by inhibiting the H /K ATPase enzyme in the stomach lining Originating from the benzimidazole class it is crucial in studies focusing on gastrointestinal and digestive health Its mechanism of action disrupts the final step of gastric acid production making it effective in vitro with activity commonly observed in the nanomolar to low micromolar range This compound is frequently employed in cell models and animal studies for drug screening and investigating potential therapeutic interventions for gastric acid-related disorders Experimental concentrations typically depend on the specific research design ensuring flexibility in various study contexts Researchers utilize its properties to explore treatment options for conditions such as ulcers and reflux disease contributing to advancements in gastroenterology